MAAT INDEX

CLAIM #43042 · Altria Group (MO) · 2025Q4 earnings call · Jan 29, 2026 · due Dec 31, 2026

Our guidance contemplates planned investments to support our contract manufacturing capabilities, limited impact on combustible and e-vapor product volumes from illicit enforcement efforts, and NJOY ACE not returning to the marketplace in 2026.

Billy Gifford · CEO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Full-year 2026 adjusted diluted EPS

It came true if: Between $5.56 and $5.72

Where: Company earnings release / 10-K adjusted diluted EPS disclosure

In context

bringing the brand to 12 unique flavor offerings. Our broadened nicotine pouch portfolio has accelerated international expansion and is generating valuable consumer insights that will inform future product development. While these are early days, we believe our expanded international portfolio and the momentum from our efforts in 2025 put us on a path towards accomplishing our long-term international smoke-free growth goals. Moving to our 2026 financial outlook, we expect to deliver 2026 full-year adjusted diluted EPS in a range of $5.56 to $5.72. This range represents a growth rate of 2.5% to 5.5% from a $5.42 base in 2025. We expect growth to be weighted to the second half of the year, reflecting a progressive increase in cigarette import and export activity over the course of the year. Our guidance contemplates planned investments to support our contract manufacturing capabilities, limited impact on combustible and e-vapor product volumes from illicit enforcement efforts, and NJOY ACE not returning to the marketplace in 2026. We remain committed to our vision and to building a portfolio of FDA-authorized smoke-free products for adult smokers and nicotine consumers who use smoke-free products. Our planned investment areas include marketplace activities, support of our smoke-free products, and continued smoke-free product research, development, and regulatory preparations. In summary, Altria Group, Inc. continued to build momentum in 2025. Our core businesses remain resilient. We advanced our smoke-free portfolio, and we opened new pathways for long-term growth in international modern oral and U.S. non-nicotine innovation. These efforts support our vision and enterprise goals. I am confident in our strategy, energized by the opportunities ahead, and grateful for our employees' commitment to delivering long-term

Verify independently

SEC filings for MO · Claim quote is verbatim from the 2025Q4 earnings call.